As you know, MoonLake Immunotherapeutics ( MLTX ) stock had a pretty rough 2025. And we're only now starting to see it recover from the lows of the $6 range we saw it drop to in lateI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges behind d ...